Asia Pacific Sexually Transmitted Diseases Testing Market By Disease Type, By the Location of Testing, By Country, Opportunity Analysis and Industry Forecast, 2021

List of Tables

The Asia Pacific Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 4.5% CAGR during the forecast period (2021-2027).

Some STDs like chlamydial and gonococcal infections in women need etiological identification of STDs that are expensive and advanced laboratory procedures. However, such laboratory tests are not accessible in the developed and developing nations for the patient's assessment, and those that are available are not helpful in determining rapid treatment recommendations. The lack of simple & quick diagnostics for the detection of most STDs, the high cost of existing STD laboratory testing, and the lack of requisite laboratory infrastructure are creating lucrative opportunities for the key market players.

In India, the government has recognized Sexually transmitted diseases (RTIs/STIs) and other reproductive tract infections (RTIs/STIs) as a public health issue, particularly because of their link to HIV infection. RTI/STI prevention, control, and management is a well-known technique for reducing reproductive morbidity among the sexually active population while also regulating the spread of HIV/AIDS in the country. In addition, National AIDS Control Programme run by the Government of India has created more awareness among population along with increasing STD testing in rural areas. Additionally, the introduction of various advanced and effective testing methods in this region would fuel the regional market growth.

The China market dominated the Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $13.00 billion by 2027. The Japan market is poised to grow a CAGR of 3.9% during (2021 - 2027). Additionally, The India market would experience a CAGR of 5.1% during (2021 - 2027).

Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

Chlamydia
Herpes simplex
Gonorrhea
Syphilis
Human papillomavirus (HPV)
Other Disease

By Location of Testing

Laboratory Testing
Point of care (POC) Testing

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

BioMerieux S.A.
Abbott Laboratories
Becton, Dickinson and Company
Hologic, Inc.
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin Molecular LLC
Danaher Corporation
Bio-Rad Laboratories, Inc.
OraSure Technologies, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
- 1.4.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
- 1.4.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct - 2021, Dec) Leading Players

Chapter 4. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type

4.1 Asia Pacific Chlamydia Market by Country
4.2 Asia Pacific Herpes simplex virus Market by Country
4.3 Asia Pacific Gonorrhea Market by Country
4.4 Asia Pacific Syphilis Market by Country
4.5 Asia Pacific Human papillomavirus (HPV) Market by Country
4.6 Asia Pacific Other Disease Market by Country

Chapter 5. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

5.1 Asia Pacific Laboratory Testing Market by Country
5.2 Asia Pacific Point of care (POC) Testing Market by Country

Chapter 6. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country

6.1 China Sexually Transmitted Diseases (STD) Testing Market
- 6.1.1 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.1.2 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Japan Sexually Transmitted Diseases (STD) Testing Market
- 6.2.1 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.2.2 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 India Sexually Transmitted Diseases (STD) Testing Market
- 6.3.1 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.3.2 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 South Korea Sexually Transmitted Diseases (STD) Testing Market
- 6.4.1 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.4.2 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 Singapore Sexually Transmitted Diseases (STD) Testing Market
- 6.5.1 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.5.2 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Malaysia Sexually Transmitted Diseases (STD) Testing Market
- 6.6.1 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.6.2 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
- 6.7.1 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
- 6.7.2 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

Chapter 7. Company Profiles

7.1 BioMerieux S.A.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
  - 7.4.5.1 Approvals and Trials:
  - 7.4.5.2 Product Launches and Product Expansions:
  - 7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
  - 7.5.5.1 Partnerships, Collaborations, and Agreements:
- 7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.6.5 Recent strategies and developments:
  - 7.6.5.1 Partnerships, Collaborations, and Agreements:
  - 7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expenses
7.8 Danaher Corporation
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.9.5 Recent strategies and developments:
  - 7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional & Segmental Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
  - 7.10.5.1 Product Launches and Product Expansions:
  - 7.10.5.2 Acquisition and Mergers:

LIST OF TABLES

TABLE 1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Sexually Transmitted Diseases (STD) Testing Market
TABLE 4 Product Launches And Product Expansions- Sexually Transmitted Diseases (STD) Testing Market
TABLE 5 Acquisition and Mergers- Sexually Transmitted Diseases (STD) Testing Market
TABLE 6 approvals and trials- Sexually Transmitted Diseases (STD) Testing Market
TABLE 7 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 29 China Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 30 China Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 31 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 32 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 33 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 34 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 35 Japan Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 36 Japan Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 37 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 38 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 39 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 40 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 41 India Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 42 India Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 43 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 44 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 45 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 46 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 47 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 48 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 49 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 50 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 51 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 52 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 53 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 54 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 55 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 56 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 57 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 58 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 59 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 60 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 61 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 62 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 63 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 64 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 65 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 66 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 67 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 68 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 69 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 70 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 71 Key information - BioMerieux S.A.
TABLE 72 Key Information - Abbott Laboratories
TABLE 73 Key information - Becton, Dickinson and Company
TABLE 74 Key information - Hologic, Inc.
TABLE 75 Key Information - Thermo Fisher Scientific, Inc.
TABLE 76 key information - F. Hoffmann-La Roche Ltd.
TABLE 77 Key information - DiaSorin Molecular LLC
TABLE 78 Key Information - Danaher Corporation
TABLE 79 Key Information - Bio-Rad Laboratories, Inc.
TABLE 80 Key information - OraSure Technologies, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Product Launches and Product Expansions : 2019, Oct - 2021, dec) Leading Players
FIG 4 Recent strategies and developments: Hologic, Inc.
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: OraSure Technologies, Inc.

Asia Pacific Sexually Transmitted Diseases Testing Market By Disease Type, By the Location of Testing, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Description

Table of Contents